Korean Circ J.  2020 Mar;50(3):248-249. 10.4070/kcj.2020.0020.

The Long and Winding Road: To the Proper Understanding of High-density Lipoprotein

• Sung J

• KMID: 2470909
• DOI: http://doi.org/10.4070/kcj.2020.0020

Abstract

No abstract available.

MeSH Terms

Lipoproteins*
Wind*
Lipoproteins

Reference

1. Cho H. High density lipoprotein cholesterol comes of age. Korean Circ J. 2007; 37:187–190.

2. Wilson PW, Abbott RD, Castelli WP. High density lipoprotein cholesterol and mortality. The Framingham Heart Study. Arteriosclerosis. 1988; 8:737–741.

3. Rubins HB, Robins SJ, Collins D, et al. Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. N Engl J Med. 1999; 341:410–418.

4. Kim KH, Kim CH, Jeong MH, et al. Differential benefit of statin in secondary prevention of acute myocardial infarction according to the level of triglyceride and high density lipoprotein cholesterol. Korean Circ J. 2016; 46:324–334.

5. Kim BJ. What do we get from recent statin and CETP inhibitors trials? J Lipid Atheroscler. 2018; 7:12–20.

6. Briel M, Ferreira-Gonzalez I, You JJ, et al. Association between change in high density lipoprotein cholesterol and cardiovascular disease morbidity and mortality: systematic review and meta-regression analysis. BMJ. 2009; 338:b92.

7. Khera AV, Cuchel M, de la Llera-Moya M, et al. Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis. N Engl J Med. 2011; 364:127–135.

8. März W, Kleber ME, Scharnagl H, et al. HDL cholesterol: reappraisal of its clinical relevance. Clin Res Cardiol. 2017; 106:663–675.

9. Choi S, Park YE, Cheon EJ, et al. Novel associations between related proteins and cellular effects of high-density lipoprotein. Korean Circ J. 2020; 50:236–247.